Deciphering Adverse Outcome Pathway Network Linked to Bisphenol F Using Text Mining and Systems Toxicology Approaches

Abstract Bisphenol F (BPF) is one of several Bisphenol A (BPA) substituents that is increasingly used in manufacturing industry leading to detectable human exposure. Whereas a large number of studies have been devoted to decipher BPA effects, much less is known about its substituents. To support decision making on BPF’s safety, we have developed a new computational approach to rapidly explore the available data on its toxicological effects, combining text mining and integrative systems biology, and aiming at connecting BPF to adverse outcome pathways (AOPs). We first extracted from different databases BPF-protein associations that were expanded to protein complexes using protein-protein interaction datasets. Over-representation analysis of the protein complexes allowed to identify the most relevant biological pathways putatively targeted by BPF. Then, automatic screening of scientific abstracts from literature using the text mining tool, AOP-helpFinder, combined with data integration from various sources (AOP-wiki, CompTox, etc.) and manual curation allowed us to link BPF to AOP events. Finally, we combined all the information gathered through those analyses and built a comprehensive complex framework linking BPF to an AOP network including, as adverse outcomes, various types of cancers such as breast and thyroid malignancies. These results which integrate different types of data can support regulatory assessment of the BPA substituent, BPF, and trigger new epidemiological and experimental studies.

[1]  M. Metzler,et al.  The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. , 1998, Environmental health perspectives.

[2]  M. Derwahl,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Estrogen Promotes Growth of Human Thyroid Tumor Cells by Different Molecular Mechanisms* , 2022 .

[3]  R. Sutherland,et al.  Estrogen and Progestin Regulation of Cell Cycle Progression , 2004, Journal of Mammary Gland Biology and Neoplasia.

[4]  K. Satoh,et al.  Study on anti-androgenic effects of bisphenol a diglycidyl ether (BADGE), bisphenol F diglycidyl ether (BFDGE) and their derivatives using cells stably transfected with human androgen receptor, AR-EcoScreen. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  C. Klinge,et al.  Resveratrol and Estradiol Rapidly Activate MAPK Signaling through Estrogen Receptors α and β in Endothelial Cells* , 2005, Journal of Biological Chemistry.

[6]  C. Klinge,et al.  Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. , 2005, The Journal of biological chemistry.

[7]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[8]  Nicolas J Cabaton,et al.  Genotoxic and endocrine activities of bis(hydroxyphenyl)methane (bisphenol F) and its derivatives in the HepG2 cell line. , 2009, Toxicology.

[9]  C. Klinge,et al.  Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. , 2010, International journal of oncology.

[10]  David M. Reif,et al.  In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.

[11]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[12]  Søren Brunak,et al.  Deciphering Diseases and Biological Targets for Environmental Chemicals using Toxicogenomics Networks , 2010, PLoS Comput. Biol..

[13]  Song-Yu Yang,et al.  Hydroxysteroid (17β) dehydrogenase X in human health and disease , 2011, Molecular and Cellular Endocrinology.

[14]  K. Audouze,et al.  Application of Computational Systems Biology to Explore Environmental Toxicity Hazards , 2011, Environmental health perspectives.

[15]  David M. Reif,et al.  Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.

[16]  Mariana F. Fernández,et al.  In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. , 2013, Toxicology and applied pharmacology.

[17]  M F Wilks,et al.  Bisphenol A--Why an adverse outcome pathway framework needs to be applied. , 2014, Toxicology letters.

[18]  Sharon Munn,et al.  Adverse outcome pathway (AOP) development I: strategies and principles. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  Andrew Worth,et al.  Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). , 2014, Regulatory toxicology and pharmacology : RTP.

[20]  F. Santini,et al.  Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. , 2014, European journal of endocrinology.

[21]  A. Vinggaard,et al.  A computational approach to mechanistic and predictive toxicology of pesticides. , 2014, ALTEX.

[22]  Soria Eladak,et al.  A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. , 2015, Fertility and sterility.

[23]  Dries Knapen,et al.  The potential of AOP networks for reproductive and developmental toxicity assay development. , 2015, Reproductive toxicology.

[24]  Natàlia Garcia-Reyero,et al.  Are adverse outcome pathways here to stay? , 2015, Environmental science & technology.

[25]  Stephen W. Edwards,et al.  An integrative data mining approach to identifying adverse outcome pathway signatures. , 2016, Toxicology.

[26]  Kazuya Sato,et al.  PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function , 2016, Haematologica.

[27]  S. Brunak,et al.  A scored human protein–protein interaction network to catalyze genomic interpretation , 2017, Nature Methods.

[28]  Antony J. Williams,et al.  The CompTox Chemistry Dashboard: a community data resource for environmental chemistry , 2017, Journal of Cheminformatics.

[29]  Thomas C. Wiegers,et al.  Chemical-Induced Phenotypes at CTD Help Inform the Predisease State and Construct Adverse Outcome Pathways , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Eeva Leinala,et al.  Integrated Approaches to Testing and Assessment: OECD Activities on the Development and Use of Adverse Outcome Pathways and Case Studies , 2018, Basic & clinical pharmacology & toxicology.

[31]  Georgia Tsiliki,et al.  A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  Sharon Munn,et al.  Adverse outcome pathway networks I: Development and applications , 2018, Environmental toxicology and chemistry.

[33]  K. Audouze,et al.  A systems biology approach to predictive developmental neurotoxicity of a larvicide used in the prevention of Zika virus transmission , 2018, Toxicology and applied pharmacology.

[34]  Daniel L Villeneuve,et al.  Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge , 2019, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  T. Thalhammer,et al.  Future Aspects for Cannabinoids in Breast Cancer Therapy , 2019, International journal of molecular sciences.

[36]  K. Ahn,et al.  Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer , 2019, Biomolecules.

[37]  Olivier Taboureau,et al.  sAOP: linking chemical stressors to adverse outcomes pathway networks , 2019, Bioinform..

[38]  Jing Wang,et al.  WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..

[39]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[40]  Karine Audouze,et al.  Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach , 2019, Environmental health perspectives.

[41]  Edward J Perkins,et al.  Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment , 2019, Environmental toxicology and chemistry.

[42]  L. Bláha,et al.  Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways , 2019, Environmental Sciences Europe.